Sodium Valproate Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports

Sodium Valproate Market Size
The global Sodium Valproate market was valued at US$ 167 million in 2023 and is anticipated to reach US$ 252.5 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-9F7142/Global_Sodium_Valproate_Market_Insights_Forecast_to_2028

Sodium Valproate Market
Valproate (VPA), and its valproic acid, sodium valproate, and valproate semisodium forms, are medications primarily used to treat epilepsy and bipolar disorder and to prevent migraine headaches. It is useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures.
North American market for Sodium Valproate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sodium Valproate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Sodium Valproate include Sanofi, AbbVie, Athenex, Fresenius Kabi, Hikma Farmaceutica, Desitin Pharmaceuticals, Wockhardt and Zentiva, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sodium Valproate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sodium Valproate.
Report Scope
The Sodium Valproate market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sodium Valproate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sodium Valproate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-9F7142/Global_Sodium_Valproate_Market_Insights_Forecast_to_2028

Segment by Type
• Injection
• Tablet
• Liquid

Segment by Application'
• Epilepsy
• Migraines
• Others

By Company
Sanofi, AbbVie, Athenex, Fresenius Kabi, Hikma Farmaceutica, Desitin Pharmaceuticals, Wockhardt, Zentiva

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-9F7142/global-sodium-valproate

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.